Differentiated thyroid cancer: a new perspective with radiolabeled somatostatin analogues for imaging and treatment of patients.

MLA

Versari, Annibale, et al. “Differentiated Thyroid Cancer: A New Perspective with Radiolabeled Somatostatin Analogues for Imaging and Treatment of Patients.” Thyroid : Official Journal of the American Thyroid Association, vol. 24, no. 4, Apr. 2014, pp. 715–26. EBSCOhost, https://doi.org/10.1089/thy.2013.0225.

APA

Versari, A., Sollini, M., Frasoldati, A., Fraternali, A., Filice, A., Froio, A., Asti, M., Fioroni, F., Cremonini, N., Putzer, D., & Erba, P. A. (2014). Differentiated thyroid cancer: a new perspective with radiolabeled somatostatin analogues for imaging and treatment of patients. Thyroid : Official Journal of the American Thyroid Association, 24(4), 715–726. https://doi.org/10.1089/thy.2013.0225

Chicago

Versari, Annibale, Martina Sollini, Andrea Frasoldati, Alessandro Fraternali, Angelina Filice, Armando Froio, Mattia Asti, et al. 2014. “Differentiated Thyroid Cancer: A New Perspective with Radiolabeled Somatostatin Analogues for Imaging and Treatment of Patients.” Thyroid : Official Journal of the American Thyroid Association 24 (4): 715–26. doi:10.1089/thy.2013.0225.